Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - CASH FROM OPERATIONS
Cash from Operations KALV - KalVista Pharmaceuticals, Inc.
-89.2 M
LAST VALUE
-6.87%
2 YEAR CAGR
-19.66%
5 YEAR CAGR
-33.78%
10 YEAR CAGR